CARDIOVASCULAR RISK IN PATIENTS WITH TREATED FAMILIAL HYPERCHOLESTEROLEMIA AND PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA

被引:1
|
作者
WAY, BPJ
BALL, MJ
THOROGOOD, M
COBBE, SM
MANN, JI
机构
[1] JOHN RADCLIFFE HOSP, LIPID CLIN, OXFORD OX3 9DU, ENGLAND
[2] RADCLIFFE INFIRM, DEPT COMMUN MED & GEN PRACTICE, OXFORD OX2 6HE, ENGLAND
关键词
D O I
10.1177/014107688607900705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:391 / 394
页数:4
相关论文
共 50 条
  • [41] MORTALITY OF CARDIOVASCULAR DISEASE IN PATIENTS WITH GENETICALLY VERIFIED FAMILIAL HYPERCHOLESTEROLEMIA
    Retterstol, K.
    Igland, J.
    Ose, L.
    Holven, K. B.
    Leren, T. P.
    Veierod, M. B.
    Mundal, L.
    ATHEROSCLEROSIS, 2016, 252 : E38 - E38
  • [42] FAMILIAL HOMOZYGOUS HYPERCHOLESTEROLEMIA - CLINICAL AND CARDIOVASCULAR FEATURES IN 18 PATIENTS
    BROOK, GJ
    KEIDAR, S
    BOULOS, M
    GRENADIER, E
    WIENER, A
    SHEHADA, N
    MARKIEWICZ, W
    BENDERLI, A
    AVIRAM, M
    CLINICAL CARDIOLOGY, 1989, 12 (06) : 333 - 338
  • [43] CARDIOVASCULAR FEATURES OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - ANALYSIS OF 16 PATIENTS
    SPRECHER, DL
    SCHAEFER, EJ
    KENT, KM
    GREGG, RE
    ZECH, LA
    HOEG, JM
    MCMANUS, B
    ROBERTS, WC
    BREWER, HB
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (01): : 20 - 30
  • [44] Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review
    Masson, Walter
    Corral, Pablo
    Barbagelata, Leandro
    Lavalle-Cobo, Augusto
    Nogueira, Juan P.
    Siniawski, Daniel
    Ray, Kausik K.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (05) : 562 - 573
  • [45] Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients
    Perez-Calahorra, Sofia
    Maria Sanchez-Hernandez, Rosa
    Plana, Nuria
    Marco-Benedi, Victoria
    Pedro-Botet, Juan
    Almagro, Fatima
    Brea, Angel
    Francisco Ascaso, Juan
    Lahoz, Carlos
    Civeira, Fernando
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (05): : 742 - 748
  • [46] Lipoprotein (a) is a risk factor for increased cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolemia
    Rana, JS
    Zwinderman, AH
    Angelique, JC
    van Aalst-Cohen, ES
    Jukema, WJ
    Kastelein, JJ
    CIRCULATION, 2005, 112 (17) : U352 - U352
  • [47] REGRESSION OF TENDON XANTHOMAS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LOVASTATIN
    ILLINGWORTH, DR
    COPE, R
    BACON, SP
    SOUTHERN MEDICAL JOURNAL, 1990, 83 (09) : 1053 - 1057
  • [48] Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels * , **
    Bianconi, Vanessa
    Banach, Maciej
    Pirro, Matteo
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (04) : 205 - 215
  • [49] RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA: A NINE-YEAR PROSPECTIVE STUDY
    Tamaeva, Bariiat
    Ezhov, Marat
    Pogorelova, Olga
    Tyurina, Aleksandra
    Chubykina, Uliana
    Tripoten, Maria
    Balakhonova, Tatyana
    ATHEROSCLEROSIS, 2024, 395
  • [50] DIETARY-MANAGEMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH SIMVASTATIN
    CHISHOLM, A
    MANN, J
    SUTHERLAND, W
    WILLIAMS, S
    BALL, M
    QUARTERLY JOURNAL OF MEDICINE, 1992, 85 (307-08): : 825 - 831